Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium

Siying He1, Hui Sun1, Yifang Huang1

  • 1Center for Gene Diagnosis & Core Lab, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.

Abstract

Insights

This study identifies key microRNAs (miRNAs) and genes involved in pterygium development, revealing extracellular matrix (ECM) breakdown and epithelial-mesenchymal transition (EMT) as potential mechanisms. MiR-29b-3p and collagen genes are highlighted as possible therapeutic targets.

Area of Science:

  • Molecular biology
  • Genomics
  • Ophthalmology

Background:

  • MicroRNAs (miRNAs) play crucial roles in disease pathogenesis.
  • Pterygium involves complex molecular changes affecting ocular surface tissues.

Purpose of the Study:

  • Identify key genes and miRNAs implicated in pterygium.
  • Elucidate the underlying molecular mechanisms of pterygium development.

Main Methods:

  • Literature review for miRNA expression data.
  • Analysis of Gene Expression Omnibus (GEO) microarray data using R.
  • Functional enrichment analysis (DAVID) and network construction (STRING, Cytoscape).

Main Results:

  • Identified 35 differentially expressed miRNAs and 301 differentially expressed genes.
  • Upregulated genes associated with extracellular matrix (ECM) organization.
  • Downregulated genes linked to cell death and apoptosis.

Conclusions:

  • Pterygium pathogenesis involves ECM breakdown and epithelial-mesenchymal transition (EMT).
  • The PI3K-Akt signaling pathway is potentially significant.
  • MiR-29b-3p and collagen genes (COL4A1, COL3A1) represent potential therapeutic targets.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
Gene-Environment Interactions01:20

Gene-Environment Interactions

Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
1.1K
Gene Flow02:39

Gene Flow

Gene flow is the transfer of genes among populations, resulting from either the dispersal of gametes or from the migration of individuals.
37.5K
Gene Families01:57

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
9.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K